Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type I interferons and SARS-CoV-2: from cells to organisms
Paul Bastard, Qian Zhang, Shen‐Ying Zhang, et al.
Current Opinion in Immunology (2022) Vol. 74, pp. 172-182
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Jérémy Manry, Paul Bastard, Adrian Gervais, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 21
Open Access | Times Cited: 153
Enhancing the immunogenicity of lipid-nanoparticle mRNA vaccines by adjuvanting the ionizable lipid and the mRNA
Bowen Li, Allen Yujie Jiang, Idris Raji, et al.
Nature Biomedical Engineering (2023)
Closed Access | Times Cited: 68
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023
Paul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Immunological Reviews (2024) Vol. 322, Iss. 1, pp. 98-112
Open Access | Times Cited: 20
The ouroboros of autoimmunity
Jean‐Laurent Casanova, Jessica N. Peel, Jean Donadieu, et al.
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 743-754
Closed Access | Times Cited: 16
Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity
Nikaïa Smith, Céline Possémé, Vincent Bondet, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 47
Microplastics dysregulate innate immunity in the SARS-CoV-2 infected lung
Cameron R. Bishop, Kexin Yan, Wilson Nguyen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
The Microbe, the Infection Enigma, and the Host
Jean‐Laurent Casanova, Laurent Abel
Annual Review of Microbiology (2024) Vol. 78, Iss. 1, pp. 103-124
Closed Access | Times Cited: 8
The antiviral state of the cell: lessons from SARS-CoV-2
Jérémie Le Pen, Charles M. Rice
Current Opinion in Immunology (2024) Vol. 87, pp. 102426-102426
Closed Access | Times Cited: 7
Primary nasal influenza infection rewires tissue-scale memory response dynamics
Samuel W. Kazer, Colette Matysiak Match, Erica M. Langan, et al.
Immunity (2024) Vol. 57, Iss. 8, pp. 1955-1974.e8
Closed Access | Times Cited: 7
Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study
Romain Arrestier, Paul Bastard, Thibaut Belmondo, et al.
Annals of Intensive Care (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Biological mechanisms underpinning the development of long COVID
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106935-106935
Open Access | Times Cited: 19
Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia
Martti Vanker, Karita Särekannu, Arnaud Fekkar, et al.
Journal of Interferon & Cytokine Research (2023) Vol. 43, Iss. 9, pp. 379-393
Open Access | Times Cited: 16
Modern concept of autoimmunity in rheumatology
Е. Л. Насонов
Rheumatology Science and Practice (2023) Vol. 61, Iss. 4, pp. 397-420
Open Access | Times Cited: 16
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 5
Immune-Mediated Inflammatory Responses of Alveolar Epithelial Cells: Implications for COVID-19 Lung Pathology
Amelia Barilli, Rossana Visigalli, Francesca Ferrari, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 618-618
Open Access | Times Cited: 23
Virus Infection and Systemic Inflammation: Lessons Learnt from COVID-19 and Beyond
Aileen Faist, Josua Janowski, Sriram Kumar, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2198-2198
Open Access | Times Cited: 23
Blood transcriptome responses in patients correlate with severity of COVID-19 disease
Ya Wang, Klaus Schughart, Tiana Maria Pelaia, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 14
Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaks
Lize Cuypers, Els Keyaerts, Samuel L. Hong, et al.
Nature Aging (2023) Vol. 3, Iss. 6, pp. 722-733
Open Access | Times Cited: 13
Warmer ambient air temperatures reduce nasal turbinate and brain infection, but increase lung inflammation in the K18-hACE2 mouse model of COVID-19
Troy Dumenil, Thuy T. Le, Daniel J. Rawle, et al.
The Science of The Total Environment (2022) Vol. 859, pp. 160163-160163
Open Access | Times Cited: 18
Human Genomics of COVID-19 Pneumonia: Contributions of Rare and Common Variants
Aurélie Cobat, Qian Zhang, Laurent Abel, et al.
Annual Review of Biomedical Data Science (2023) Vol. 6, Iss. 1, pp. 465-486
Open Access | Times Cited: 10
Life-threatening infections in human newborns: Reconciling age-specific vulnerability and interindividual variability
A. Borghesi
Cellular Immunology (2024) Vol. 397-398, pp. 104807-104807
Closed Access | Times Cited: 3
LINC01002 functions as a ceRNA to regulate FRMD8 by sponging miR-4324 for the development of COVID-19
Xinyi Kong, Qinjin Wang, Xumeng Wang, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
COVID-19 Pneumonia and Cytokine Storm Syndrome
Frank L. van de Veerdonk
Advances in experimental medicine and biology (2024), pp. 307-319
Closed Access | Times Cited: 3
SARS-CoV-2 Omicron Induces Enhanced Mucosal Interferon Response Compared to other Variants of Concern, Associated with Restricted Replication in Human Lung Tissues
Or Alfi, Motasem Hamdan, Ori Wald, et al.
Viruses (2022) Vol. 14, Iss. 7, pp. 1583-1583
Open Access | Times Cited: 18
Correlation between Type I Interferon Associated Factors and COVID-19 Severity
Dóra Bencze, Tünde Fekete, Kitti Pázmándi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10968-10968
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top